MDR-001
A Phase III Study to Evaluate the Efficacy and Safety of MDR-001 in Adult Participants With Overweight or Obesity (MOBILE)
MindRank AI Ltd · Phase 3 · Not yet recruiting · Enrollment 738
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| MDR-001 Dose 1 | n/r | n/r | n/r | n/r | n/r |
| MDR-001 Dose 2 | n/r | n/r | n/r | n/r | n/r |
| placebo | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.